<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Care</journal-id><journal-id journal-id-type="hwp">diacare</journal-id><journal-id journal-id-type="pmc">dcare</journal-id><journal-id journal-id-type="publisher-id">Diabetes Care</journal-id><journal-title-group><journal-title>Diabetes Care</journal-title></journal-title-group><issn pub-type="ppub">0149-5992</issn><issn pub-type="epub">1935-5548</issn><publisher><publisher-name>American Diabetes Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28420696</article-id><article-id pub-id-type="pmc">5439410</article-id><article-id pub-id-type="publisher-id">er06c</article-id><article-id pub-id-type="doi">10.2337/dc17-er06c</article-id><article-categories><subj-group subj-group-type="heading"><subject>Errata</subject></subj-group></article-categories><title-group><article-title>Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:<related-article id="d35e32" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.2337/dc16-0917" vol="39" page="2026">2026&#x02013;2035</related-article></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rosenstock</surname><given-names>Julio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aronson</surname><given-names>Ronnie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grunberger</surname><given-names>George</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hanefeld</surname><given-names>Markolf</given-names></name></contrib><contrib contrib-type="author"><name><surname>Piatti</surname><given-names>PierMarco</given-names></name></contrib><contrib contrib-type="author"><name><surname>Serusclat</surname><given-names>Pierre</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Xi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Tianyue</given-names></name></contrib><contrib contrib-type="author"><name><surname>Niemoeller</surname><given-names>Elisabeth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Souhami</surname><given-names>Elisabeth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Davies</surname><given-names>Melanie</given-names></name></contrib><on-behalf-of>on behalf of the LixiLan-O Trial Investigators</on-behalf-of></contrib-group><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>18</day><month>4</month><year>2017</year></pub-date><volume>40</volume><issue>6</issue><fpage seq="1">809</fpage><lpage>809</lpage><permissions><copyright-statement>&#x000a9; 2017 by the American Diabetes Association.</copyright-statement><copyright-year>2017</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="vor" start_date="2017-05-22">http://www.diabetesjournals.org/content/license</ali:license_ref><license-p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at <ext-link ext-link-type="uri" xlink:href="http://www.diabetesjournals.org/content/license">http://www.diabetesjournals.org/content/license</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="dc17er06c.pdf"/><counts><page-count count="1"/></counts></article-meta></front><body><p>In the Research Design and Methods section of the abstract of the above-mentioned article, the value of &#x0201c;&#x0003c;5.6 mmol/mol&#x0201d; should read &#x0201c;&#x0003c;5.6 mmol/L.&#x0201d;</p><p>The online issue has been corrected to reflect this change.</p></body></article>